Detalhe da pesquisa
1.
MYD88 L265P mutation and interleukin-10 detection in cerebrospinal fluid are highly specific discriminating markers in patients with primary central nervous system lymphoma: results from a prospective study.
Br J Haematol
; 193(3): 497-505, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33620087
2.
R-CHOP preceded by blood-brain barrier permeabilization with engineered tumor necrosis factor-α in primary CNS lymphoma.
Blood
; 134(3): 252-262, 2019 07 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-31118164
3.
Clonal Hematopoiesis of Indeterminate Potential in Patients with Immunoglobulin Light Chain AL Amyloidosis.
Blood Adv
; 2024 Apr 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38652890
4.
Targeted Treatment of Relapsed or Refractory Follicular Lymphoma: Focus on the Therapeutic Potential of Mosunetuzumab.
Cancer Manag Res
; 15: 257-264, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-36941881
5.
Novel Drugs and Radiotherapy in Relapsed Lymphomas: Abscopal Response and Beyond.
Cancers (Basel)
; 15(10)2023 May 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-37345088
6.
Early progression and transformation of a splenic diffuse red pulp small B-cell lymphoma with NOTCH1, ARID2, CREBBP, and TNFRSF14 gene mutations.
Leuk Res Rep
; 20: 100384, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37664441
7.
Association of Serum Free Light Chain Level with Long Term Kidney Function in Patients with Newly Diagnosed Multiple Myeloma.
Nephron
; 2023 Dec 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-38113858
8.
Acute kidney injury and chronic kidney disease in umbilical cord blood transplant recipients.
Front Oncol
; 13: 1186503, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37260983
9.
A Case of Bladder Large Cell Carcinoma with Review of the Literature.
Case Rep Oncol
; 15(1): 326-337, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35529284
10.
Management of relapsed or refractory large B-cell lymphoma in patients ineligible for CAR-T cell therapy.
Expert Rev Hematol
; 15(3): 215-232, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-35184664
11.
Polatuzumab Vedotin for Relapsed/Refractory Aggressive B-cell Lymphoma: A Multicenter Post-marketing Analysis.
Clin Lymphoma Myeloma Leuk
; 21(3): 170-175, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33431309
12.
Improving the antitumor activity of R-CHOP with NGR-hTNF in primary CNS lymphoma: final results of a phase 2 trial.
Blood Adv
; 4(15): 3648-3658, 2020 08 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-32766857
13.
Low doses ATLG as GvHD prophylaxis in allogeneic hematopoietic stem cell transplantation for lymphomas.
Bone Marrow Transplant
; 56(9): 2295-2298, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34108674